Facial angiofibroma
Treatment of facial angiofibroma associated with tuberous sclerosis complex
Sirolimus
Hyftor 2mg/g gel
Prescribing Notes:
- For the treatment of adult patients with facial angiofibroma (facial AF) associated with tuberous sclerosis complex (TSC).
History Notes
27/05/2026
Regional formulary chapter launched.
Treatment of facial angiofibroma associated with tuberous sclerosis complex
Sirolimus
Hyftor 2mg/g gel
Prescribing Notes:
- For the treatment of paediatric patients aged 6 and above with facial angiofibroma (facial AF) associated with tuberous sclerosis complex (TSC).
History Notes
27/05/2026
Regional formulary chapter launched.